BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
23.50
+0.46 (1.97%)
Nov 21, 2024, 1:19 PM EST - Market open
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $4.44 billion as of November 21, 2024. Its market cap has decreased by -13.15% in one year.
Market Cap
4.44B
Enterprise Value
5.83B
1-Year Change
-13.15%
Ranking
Category
Stock Price
$23.50
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $4.44B, an increase of 33.75%. That is a compound annual growth rate of 5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 4.35B | -38.00% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | 8.72B | 101.23% |
| Dec 31, 2019 | 4.33B | 30.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 4.72B |
| Axsome Therapeutics | 4.58B |
| Alkermes | 4.52B |
| Integer Holdings | 4.47B |
| TG Therapeutics | 4.47B |
| Ultragenyx Pharmaceutical | 4.28B |
| Haemonetics | 4.27B |
| Oscar Health | 4.20B |